Male gender was independently associated with a 2.639 times higher risk of cardiac death compared to female gender in patients with HFpEF.
Observational (n=260)
No
Does male gender affect the risk of cardiac death, heart failure hospitalization, and all-cause mortality in patients with HFpEF?
In a well-characterized HFpEF cohort, male patients exhibited a more pronounced right heart phenotype and had a significantly higher risk of cardiac death compared to female patients.
Effect estimate: HR 2.639 (95% CI 1.023-6.805)
Absolute Event Rate: 16.5% vs 6.1%
p-value: p=0.045
Abstract Heart failure with preserved ejection fraction (HFpEF) affects more women than men, suggesting gender to play a major role in disease evolution. However, studies investigating gender differences in HFpEF are limited. In the present study we aimed to describe gender differences in a well-characterized HFpEF cohort. Consecutive HFpEF patients underwent invasive hemodynamic assessment, cardiac magnetic resonance imaging and exercise testing. Study endpoints were: cardiac death, a combined endpoint of HF hospitalization or cardiac death and all-cause death. 260 HFpEF patients were prospectively enrolled. Men were more compromised with regard to exercise capacity and had significantly more co-morbidities. Men had more pronounced pulmonary vascular disease with higher diastolic pressure gradients and a lower right ventricular EF. During follow-up, 9.2% experienced cardiac death, 33.5% the combined endpoint and 17.3% all-cause death. Male gender was independently associated with cardiac death, but neither with the combined endpoint nor with all-cause mortality. We detected clear gender differences in HFpEF patients. Cardiac death was more common among men, but not all-cause death. While men are more prone to develop a right heart phenotype and die from HFpEF, women are more likely to die with HFpEF.
Duca et al. (Fri,) conducted a observational in Heart failure with preserved ejection fraction (HFpEF) (n=260). Male gender was independently associated with a 2.639 times higher risk of cardiac death compared to female gender in patients with HFpEF.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: